X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (103) 103
life sciences & biomedicine (96) 96
humans (76) 76
610 medicine & health (56) 56
gastroenterology & hepatology (50) 50
clinic for gastroenterology and hepatology (48) 48
female (48) 48
male (48) 48
adult (39) 39
middle aged (37) 37
inflammatory bowel disease (29) 29
aged (27) 27
gastroenterology and hepatology (27) 27
risk factors (23) 23
young adult (21) 21
adolescent (17) 17
ulcerative colitis (15) 15
aged, 80 and over (13) 13
animals (13) 13
child (13) 13
intestine (13) 13
patients (13) 13
treatment outcome (13) 13
biochemistry & molecular biology (12) 12
care and treatment (12) 12
gastroenterology (12) 12
crohn's disease (11) 11
health aspects (11) 11
inflammatory bowel diseases (11) 11
research (11) 11
switzerland - epidemiology (11) 11
colon (10) 10
prospective studies (10) 10
surgery (10) 10
child, preschool (9) 9
digestive system diseases (9) 9
follow-up studies (9) 9
medical clinic (9) 9
mice (9) 9
retrospective studies (9) 9
switzerland (9) 9
abridged index medicus (8) 8
analysis (8) 8
colitis (8) 8
general & internal medicine (8) 8
hela cells (8) 8
infant (8) 8
inflammation (8) 8
medicine, general & internal (8) 8
multidisciplinary sciences (8) 8
proteins (8) 8
research article (8) 8
science & technology - other topics (8) 8
570 life sciences; biology (7) 7
cohort studies (7) 7
crohn’s disease (7) 7
diagnosis (7) 7
immunology (7) 7
salmonella (7) 7
salmonella typhimurium - pathogenicity (7) 7
surveys and questionnaires (7) 7
time factors (7) 7
usage (7) 7
abdomen (6) 6
bacteria (6) 6
biology (6) 6
biology and life sciences (6) 6
further section (6) 6
hepatology (6) 6
hospitals (6) 6
irritable bowel syndrome (6) 6
liver (6) 6
medical research (6) 6
medicine and health sciences (6) 6
medicine, experimental (6) 6
mice, inbred c57bl (6) 6
motility (6) 6
multivariate analysis (6) 6
oncology (6) 6
salmonella infections - microbiology (6) 6
sex factors (6) 6
360 social problems & social services (5) 5
acute disease (5) 5
administration, oral (5) 5
arthritis (5) 5
bacterial proteins - metabolism (5) 5
binding sites (5) 5
cancer (5) 5
cell biology (5) 5
colorectal cancer (5) 5
crohn disease - complications (5) 5
crohn disease - drug therapy (5) 5
diarrhea (5) 5
digestive system (5) 5
disease models, animal (5) 5
drug therapy (5) 5
endoscopy (5) 5
epidemiology (5) 5
genetic aspects (5) 5
infant, newborn (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article
United European gastroenterology journal, ISSN 2050-6406, 12/2018, Volume 6, Issue 10, pp. 1598 - 1600
Journal Article
Clinical gastroenterology and hepatology, ISSN 1542-3565, 09/2019, Volume 17, Issue 10, pp. 1969 - 1981.e15
Background & AimsWidespread screening for colorectal cancer (CRC) has reduced its incidence and mortality. Previous studies investigated the economic effects... 
Gastroenterology and Hepatology | Contributing Factors | Decision-Making | Economic Evidence | Simulation Models | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Medical examination | Colonoscopy | Analysis | Oncology, Experimental | Mortality | Colorectal cancer | Models | Research institutes | Research | Diagnosis | Blood | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2010, Volume 363, Issue 26, pp. 2499 - 2510
In this clinical trial, rivaroxaban, an oral factor Xa inhibitor, was effective in the initial and continued treatment of symptomatic venous thromboembolism;... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - drug therapy | Warfarin - therapeutic use | Rivaroxaban | Vitamin K - antagonists & inhibitors | Injections, Subcutaneous | Female | Morpholines - adverse effects | Morpholines - therapeutic use | Acute Disease | Double-Blind Method | Venous Thrombosis - drug therapy | Administration, Oral | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Acenocoumarol - adverse effects | Intention to Treat Analysis | Pulmonary Embolism - drug therapy | Acenocoumarol - therapeutic use | Aged | Hemorrhage - chemically induced | Anticoagulants (Medicine) | Thromboembolism | Drug therapy | Health aspects | Risk factors | Anticoagulants | Bone surgery | Veins & arteries | Index Medicus | Abridged Index Medicus | Venous Thrombosis | Factor Xa | Hemorrhage | Life Sciences | Venous Thromboembolism | Thiophenes | Acenocoumarol | Vitamin K | Warfarin | Enoxaparin | Morpholines | Human health and pathology | Pulmonary Embolism | MEDICIN OCH HÄLSOVETENSKAP | Oral | MEDICAL AND HEALTH SCIENCES | Administration | chemically induced | drug therapy | Subcutaneous | antagonists & inhibitors | Injections | adverse effects | therapeutic use
Journal Article
PloS one, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0185193 - e0185193
Journal Article